Digoxin vs Bisoprolol for AFib, Risk of Second Cancer After a First Cancer, Review of GERD and more

JAMA Editor’s Summary

Digoxin vs Bisoprolol for AFib, Risk of Second Cancer After a First Cancer, Review of GERD and more

Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the

December 22, 2020

Listen on your favorite player Take me to this show’s page

Newer →

Effect of Tri- vs Quadrivalent Flu Vaccination on Mortality, COPD Exacerbation and VTE, Review of Crohn Disease, and more

← Older

VEGF Inhibitor vs Vitrectomy for Diabetic Retinopathy, FFR-Based PCI, USPSTF Guideline on HBV Screening, and more

Facebook Twitter Buffer LinkedIn WhatsApp

Digoxin vs Bisoprolol for AFib, Risk of Second Cancer After a First Cancer, Review of GERD and more

Editor’s Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the December 22/29, 2020 issue

Listen on your favorite player

New to Podcasts? It's easy to get started!

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

We gratefully acknowledge the many organizations that have generously supported our podcasts and platform.

Network Sponsors and Advertisers

Event and Media Partners

00:00

00:00